about
Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patientsBactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptorStructural equation modeling of latent growth curves of weight gain among treated tuberculosis patients.Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
P50
description
researcher ORCID ID = 0000-0002-4491-7553
@en
wetenschapper
@nl
name
Perumal Venkatesan
@ast
Perumal Venkatesan
@en
Perumal Venkatesan
@es
Perumal Venkatesan
@nl
type
label
Perumal Venkatesan
@ast
Perumal Venkatesan
@en
Perumal Venkatesan
@es
Perumal Venkatesan
@nl
prefLabel
Perumal Venkatesan
@ast
Perumal Venkatesan
@en
Perumal Venkatesan
@es
Perumal Venkatesan
@nl
P106
P1153
36865838900
P31
P496
0000-0002-4491-7553